Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 3,8-dihydroxy-6h-dibenzo(b,d)pyran-6-one
1. 1143-70-0
2. 3,8-dihydroxy-6h-benzo[c]chromen-6-one
3. 3,8-dihydroxyurolithin
4. 3,8-dihydroxybenzo[c]chromen-6-one
5. 3,8-dihydroxy-6h-dibenzo(b,d)pyran-6-one
6. 6h-dibenzo[b,d]pyran-6-one, 3,8-dihydroxy-
7. 3,8-hydroxydibenzo-alpha-pyrone
8. Ilj8nef6dt
9. 3,8-dihydroxy-6h-dibenzo[b,d]pyran-6-one
10. Mfcd20275235
11. 6h-dibenzo(b,d)pyran-6-one, 3,8-dihydroxy-
12. Uro-a
13. 3,8-dihydroxybenzo(c)chromen-6-one
14. Urolithin-a
15. Unii-ilj8nef6dt
16. 3,8-dihydroxy-urolithin
17. Schembl803408
18. Chembl1836264
19. Dtxsid40150694
20. Chebi:168442
21. Urolithin A, >=97% (hplc)
22. Ex-a4345
23. S5312
24. Zinc13484727
25. Akos028108778
26. Ccg-266776
27. Cs-6305
28. Db15464
29. Ac-31959
30. Ds-19328
31. Sy070232
32. Db-122496
33. Hy-100599
34. Ft-0778244
35. Y10574
36. A901528
37. J-003086
38. Q15634120
39. 2-biphenylcarboxylic Acid, 2',4,4'-trihydroxy-, Delta-lactone
| Molecular Weight | 228.20 g/mol |
|---|---|
| Molecular Formula | C13H8O4 |
| XLogP3 | 2.3 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 0 |
| Exact Mass | 228.04225873 g/mol |
| Monoisotopic Mass | 228.04225873 g/mol |
| Topological Polar Surface Area | 66.8 Ų |
| Heavy Atom Count | 17 |
| Formal Charge | 0 |
| Complexity | 317 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A Urolithin A manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Urolithin A, including repackagers and relabelers. The FDA regulates Urolithin A manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Urolithin A API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Urolithin A manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Urolithin A supplier is an individual or a company that provides Urolithin A active pharmaceutical ingredient (API) or Urolithin A finished formulations upon request. The Urolithin A suppliers may include Urolithin A API manufacturers, exporters, distributors and traders.
click here to find a list of Urolithin A suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Urolithin A Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Urolithin A GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Urolithin A GMP manufacturer or Urolithin A GMP API supplier for your needs.
A Urolithin A CoA (Certificate of Analysis) is a formal document that attests to Urolithin A's compliance with Urolithin A specifications and serves as a tool for batch-level quality control.
Urolithin A CoA mostly includes findings from lab analyses of a specific batch. For each Urolithin A CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Urolithin A may be tested according to a variety of international standards, such as European Pharmacopoeia (Urolithin A EP), Urolithin A JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Urolithin A USP).
LOOKING FOR A SUPPLIER?
